Aurinia Pharmaceuticals Inc (AUPH)

Aurinia Pharmaceuticals Inc (AUPH)

Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Aurinia Pharmaceuticals Inc (AUPH) Profile

Aurinia Pharmaceuticals Inc (AUPH.xnas) is a late-stage clinical biopharmaceutical company headquartered in Victoria, British Columbia, Canada. Aurinia is developing and commercialising therapies to treat targeted patient populations with serious diseases with high unmet medical needs. The company employs 294 people, has a US commercial hub in Rockville and Maryland, and extends to other global areas. The Aurinia Pharmaceuticals Inc stock is listed on the NASDAQ and had a market capitalisation of $2.41B (USD) as of January 2022. In December 2020, Aurinia Pharmaceuticals and Otsuka Pharmaceuticals entered a collaboration and licensing agreement to develop and commercial oral voclosporin as a treatment for Lupus nephritis (LN) in the European Union, Japan, United Kingdom, and Russia, Switzerland, Norway, Belarus, Iceland, Liechtenstein, and Ukraine. Aurinia Pharmaceuticals announced positive topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of LUPKYNIS (voclosporin) for the treatment of adults with active lupus nephritis. The LUPKYNIS is the first and only approved medicine from FDA with 3 years of pivotal trial results, including long-term safety data, within LN.

Holding cost
Trading hours in US Eastern Time

Start Trading Aurinia Pharmaceuticals Inc (AUPH)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as acciones, commodities, y foreign exchange, y índices.

6 razones para operar CFD sobre acciones con FP Markets

Regulado en Australia
Bróker de forex y CFD

A largo o a corto

Increase your ability to profit in all market conditions Leverage options up to 20:1

Ejecución DMA
(Acceso directo al mercado)

Precios de acciones transparentes
y en tiempo real Control, funcionalidad y liquidez abundante
Total profundidad de mercado
y vista de órdenes en la cola

Plataformas avanzadas
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

Soporte multilingüe 24/7

Award winning support & personal account managers

Exposición global

Márgenes bajos y comisiones competitivas en +10.000 productos en acciones globales en cuatro continentes

Gana dividendos

On long positions No ownership of physical shares necessary

Empieza a hacer trading
en cuestión de minutos.

Abre una cuenta ahora

bullet Accede a más de 10.000 instrumentos financieros
bullet Apertura y cierre automático de posiciones
bullet Noticias y agenda económica
bullet Indicadores técnicos y gráficos
bullet Muchas más herramientas incluidas

Al proporcionar su correo electrónico, usted acepta la política de privacidad de FP Markets y está de acuerdo en recibir futuros mensajes de marketing por parte de FP Markets. Puede darse de baja en cualquier momento.

Mapa del sitio | © FP Markets 2022
Get instant Updates in Telegram